Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tramadol Administered Orally to Healthy Subjects for the Improvement of Its Detection in Biological Matrices in the Context of Anti-Doping Control

NCT05925686 is registered in ClinicalTrials.gov with Parc de Salut Mar as lead sponsor.

NCT NCT05925686
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05925686 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tramadol Administered Orally to Healthy Subjects for the Improvement of Its Detection in Biological Matrices in the Context of Anti-Doping Control
Lead sponsor
Parc de Salut Mar
Phase
Phase 1
Overall status
Completed
Start date
June 1, 2023
Completion date
October 17, 2023
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy